Table 2 |
||||||
|
Risk of paroxysmal atrial fibrillation associated with age, sex, and other factors |
||||||
|
Paroxysmal AF cases |
Controls |
|||||
|
n = 525 |
(%) |
n = 5000 |
(%) |
OR* |
(95% CI) |
|
|
|
||||||
|
Age |
||||||
|
40–49 |
31 |
(5.9) |
1565 |
(31.3) |
1 |
|
|
50–59 |
62 |
(11.8) |
1343 |
(26.9) |
2.1 |
(1.3–3.2) |
|
60–69 |
131 |
(25.0) |
997 |
(19.9) |
5.0 |
(3.3–7.5) |
|
70–79 |
188 |
(35.8) |
769 |
(15.4) |
8.3 |
(5.5–12.5) |
|
80–89 |
113 |
(21.5) |
326 |
(6.5) |
10.9 |
(7–17.1) |
|
Sex |
||||||
|
Female |
268 |
(51.0) |
2647 |
(52.9) |
1 |
|
|
Male |
257 |
(49.0) |
2353 |
(47.1) |
1.3 |
(1.0–1.6) |
|
Smoking† |
||||||
|
Non-smoker |
313 |
(59.6) |
2736 |
(54.7) |
1 |
|
|
Smoker |
94 |
(17.9) |
1226 |
(24.5) |
0.8 |
(0.6–1.0) |
|
Ex-smoker |
42 |
(8.0) |
280 |
(5.6) |
1.0 |
(0.7–1.5) |
|
Body mass index (BMI) † |
||||||
|
<20 |
25 |
(4.8) |
201 |
(4.0) |
1.4 |
(0.9–2.4) |
|
20–24 |
135 |
(25.7) |
1466 |
(29.3) |
1 |
|
|
25–29 |
162 |
(30.9) |
1420 |
(28.4) |
1.1 |
(0.8–1.4) |
|
30+ |
62 |
(11.8) |
601 |
(12.0) |
1.1 |
(0.8–1.5) |
|
Alcohol consumption (units per week) †# |
||||||
|
None |
185 |
(35.2) |
1597 |
(31.9) |
1 |
|
|
1–7 units |
114 |
(21.7) |
1112 |
(22.2) |
1.2 |
(0.9–1.6) |
|
8–21 units |
69 |
(13.1) |
718 |
(14.4) |
1.4 |
(1.0–1.9) |
|
>21 units |
31 |
(5.9) |
292 |
(5.8) |
1.7 |
(1.1–2.6) |
|
Comorbidity |
||||||
|
IHD |
156 |
(29.7) |
415 |
(8.3) |
2.1 |
(1.6–2.6) |
|
Valvular disease |
30 |
(5.7) |
41 |
(0.8) |
4.2 |
(2.4–7.3) |
|
Heart failure |
81 |
(15.4) |
117 |
(2.3) |
2.5 |
(1.8–3.5) |
|
Hypertension |
197 |
(37.5) |
859 |
(17.2) |
1.4 |
(1.2–1.8) |
|
Cerebrovascular disease |
68 |
(13.0) |
195 |
(3.9) |
1.5 |
(1.1–2.1) |
|
Diabetes |
36 |
(6.9) |
194 |
(3.9) |
0.9 |
(0.6–1.4) |
|
Hyperthyroidism |
19 |
(3.6) |
44 |
(0.9) |
3.6 |
(2.0–6.5) |
|
|
||||||
|
*OR: Odds ratio adjusted by age, sex and all the variables in the table, using unconditional logistic regression. †Missing data in smoking (15.1%), BMI (26.3%) and alcohol use (25.5%). # 1 unit = 10 mL of pure ethanol. |
||||||
|
Ruigómez et al. BMC Cardiovascular Disorders 2005 5:20 doi:10.1186/1471-2261-5-20 |
||||||